Dietary intake in type 1 diabetes at different stages of diabetic kidney disease by Ahola, Aila J. et al.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 7 5Contents available at ScienceDirectDiabetes Research
and Clinical Practice
journal homepage: www.elsevier.com/locate/diabresDietary intake in type 1 diabetes at different stages
of diabetic kidney diseasehttps://doi.org/10.1016/j.diabres.2019.06.016
0168-8227/ 2019 Published by Elsevier B.V.
* Corresponding author at: Folkha¨lsan Research Center, Biomedicum Helsinki C318b, PO Box 63, FI-00014 University of Helsin
(P.-H. Groop).
E-mail address: per-henrik.groop@helsinki.fi (P.-H. Groop).Aila J. Ahola a,b,c, Carol Forsblom a,b,c, Valma Harjutsalo a,b,c,d, Per-Henrik Groop a,b,c,e,*
a Folkha¨lsan Institute of Genetics, Folkha¨lsan Research Center, Helsinki, Finland
bAbdominal Center Nephrology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
cResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Finland
dDiabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland
eDepartment of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, AustraliaA R T I C L E I N F O A B S T R A C TArticle history:
Received 15 February 2019
Received in revised form
27 May 2019
Accepted 25 June 2019
Available online 1 July 2019
Keywords:
Dietary patterns
Energy and nutrients
Food intake
Kidney function
Type 1 diabetesAim: Diet plays an important role in the kidney health of individuals with type 1 diabetes.
However, not much is known about dietary practices at different stages of diabetic
nephropathy. We aimed at investigating food intake, dietary patterns, and nutrient intakes
in individuals with type 1 diabetes differing in renal status.
Methods: Data were available from 1874 individuals with type 1 diabetes (45% men, age 48
± 13 years). Diet was assessed at the levels of food items and diet patterns (diet question-
naire), and energy and nutrient intakes (food record). Six groups were formed based on
the eGFR or dialysis and transplantation status.
Results: Reductions in liquid-milk product and salt consumption, and increase in special
diet adherence were observed at the early stages of eGFR decline. Reduced coffee consump-
tion was observed after eGFR was <30 ml/min/1.73 m2. With advancing kidney failure, rye
bread consumption decreased, but that of wheat bread increased. Compared to those with
intact kidney function (the index group), the Fish and vegetable diet pattern scores were
higher in individuals with mildly-to-severely decreased eGFR. Instead, the Sweet pattern
scores were lower than in the index group in all other groups. Energy intake was lower
in all groups compared to those with intact kidney function. Advancing kidney failure
was associated with reductions in protein intake per body weight, and in the intakes of
sodium, potassium, calcium, and phosphorus.
Conclusions: Differences in the dietary intake are seen already at the early stages of kidney
function decline.
 2019 Published by Elsevier B.V.1. Introduction outcomes related to renal replacement therapies are importantIncreasing prevalence of chronic kidney disease (CKD), high
costs of treating individuals with kidney failure, and poorhealth challenges across the globe [1]. It has been suggested,
that the overall burden of CKD is largely driven by the
increase in the prevalence of diabetes, mainly that of type 2ki, Finland
2 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 7 5[2]. However CKD is a major health concern also in type 1 dia-
betes (T1D) as, over the course of a lifetime, diabetic
nephropathy affects approximately one third of this popula-
tion [3]. Importantly, the presence of diabetic nephropathy
greatly increases the risk of premature death of patients with
T1D [4].
Targeting the blood glucose and blood pressure levels near
those physiological are among the major approaches for min-
imizing the risk of diabetes complications. In addition modi-
fiable life-style factors, such as diet, may play an important
role in the progression and management of diabetic kidney
disease [5]. With respect to food intake, overall healthy diet,
and reduced intakes of sodium and protein have been com-
monly acknowledged [6,7].
For the prevention of diabetic kidney disease no particular
dietary recommendation exist, however. Instead, the current
recommendations stress the need for individualized meal
plan; one that, amongst others, takes into consideration the
patient’s age, size, metabolic goals, and stage of kidney dis-
ease [8,9]. As with deteriorating renal function the kidneys’
ability to remove waste products and extra water from the
blood gets compromised, phosphorus, potassium, and fluid
restrictions are typically issued in the pre-dialysis period
[10]. These dietary restrictions may lead to limited intakes
of fruits, vegetables, grains, and nuts, and therefore impair
the overall quality of the diet [11]. In contrast, the advent of
dialysis poses new challenges in the form of protein loss in
the dialysate and increased risk of anorexia due to uraemia,
nausea, and loss of appetite, which again needs to be
reflected in the diet plan [10,12].
While a number of studies have been published about diet-
ary intake and the risk of diabetic kidney disease, the studies
describing the actual diets of individuals with T1D at different
stages of renal disease are practically non-existent. In this
study, we wanted to fill in this gap in knowledge and describe
the diets of the Finnish Diabetic Nephropathy (FinnDiane)
Study participants divided by stages of kidney disease. To
get an extensive view, the dietary intake was investigated at
the levels of food consumption, dietary patterns, and
nutrients.
2. Materials and methods
2.1. Subjects
All individuals with T1D participating in the FinnDiane Study
were included in this cross-sectional observational study if
they had known renal status and had completed a diet ques-
tionnaire within a year from the renal assessment. T1D was
defined as diabetes onset before the age of 35 years, and per-
manent insulin treatment, initiated within a year from the
diagnosis. The Ethics Committee of The Helsinki and Uusi-
maa Hospital District approved the study protocol. Written
informed consent was obtained from all participants.
2.2. Clinical and laboratory data
At the study visit, all participants were thoroughly investi-
gated [13]. This included measurements of body weight,height, blood pressure, and waist and hip circumference.
Body mass index (BMI; kg/m2) was calculated and participants
were categorized into those underweight (BMI < 18.5 kg/m2),
normal-weight (BMI 18.5–<25 kg/m2), overweight (BMI  25–
<30 kg/m2), and obese (30 kg/m2). Waist-to-hip ratio, and
the mean of two blood pressure measurements were calcu-
lated. HbA1c was measured locally using a standardized assay.
Blood was drawn for subsequent central analyses of serum
lipids, lipoproteins, and creatinine concentrations. Fasting
was not required, and a light breakfast was allowed to prevent
or treat hypoglycaemia. Serum creatinine concentration was
used to calculate the estimated glomerular filtration rate
(eGFR as ml/min/1.73 m2) as described by Levey et al [14].
Using a standardized form, the attending physician recorded
the participant’s medication use and diabetes complications.
From these records and medical files, we obtained data on
dialysis and kidney transplantation. Following classifications
were made; normal or high eGFR (eGFR90), mildly decreased
eGFR (eGFR60–89), mildly to severely decreased eGFR
(eGFR30–59), severely decreased eGFR (eGFR<30), dialysis, and
kidney transplantation. Classifications based on eGFR are
modified from the KDIGO 2012 clinical practice guidelines
for the evaluation and management of CKD [15]. Smoking
was self-reported.
2.3. Dietary intake
Two methods to study dietary intake were used as previously
described [16]. In short, participants first completed a vali-
dated diet questionnaire [17]. Using this questionnaire, our
aim was to obtain an overall picture of the participants’ diet-
ary practices. Dietary habits related to coffee, tea, liquid milk
product, bread, spread, cooking fat, and salt consumption
were queried. Participants reported the use of probiotic prod-
ucts and dietary supplements, and whether they adhered to
any special diets or had received dietary counselling from
health-care professionals. On a five-level scale, the level of
adherence with these recommendations was estimated. Indi-
viduals self-reportedly following the recommendations
always or most of the time were considered as ‘‘compliant”.
Included was also a 19-item food frequency questionnaire
(FFQ) where consumption frequencies of fish dishes, meat
dishes, poultry, sausages and cold-cuts, eggs, legumes, fresh
vegetables, cooked vegetables, potatos, pasta and rice, fruits
and berries, full-fat cheese, low-fat cheese, yoghurt and curd,
ice cream, soft drinks, sweet pastries, sweets, and fried and
grilled foods were reported using a seven-level response scale
(several times per day, once a day, 4–6 times per week, 2–3
times per week, once a week, 1–3 times per month, and less
frequently or never). Upon returning the diet questionnaire,
participants were sent an allocated 3-day diet record covering
two weekdays and one weekend day. Another 3-day record
was completed within 2–3 months. Mean dietary intake was
calculated based on the 6-day food record for those complet-
ing both records, and the 3-day food record for those complet-
ing only the first recording. Detailed instructions for
completing the record were provided. AivoDiet software (ver-
sion 2.0.2.3, AIVO, Turku, Finland) was used to calculate
energy and nutrient contents. Individuals with reported
Ta le 1 – Participant characteristics divided by the kidney status.
eGFR90n = 1118 eGFR60–89n = 396 eGFR30–59n = 115 eGFR<30n = 62 Dialysis n = 73 Transplant n = 110
Men, % 44.7 37.1b 48.7 41.9 58.9a 56.4a
C rrent smoker, % 15.6 11.4a 16.7 11.7 14.3 15.4
A e, years 43 (35, 53) 58 (49, 65)c 59 (50, 64)c 54 (47, 62)c 49 (43, 53)c 52 (46, 60)c
D abetes duration, years 24 (18, 34) 38 (28, 47)c 42 (34, 49)c 39 (30, 46)c 37 (29, 43)c 40 (35, 44)c
S P, mmHg 133 (122, 144) 139 (127, 156)c 148 (134, 163)c 143 (135, 157)c 145 (132, 162)c 153 (137, 167)c
D P, mmHg 79 (72, 85) 75 (69, 81)c 77 (69, 83)a 80 (68, 87) 79 (71, 88) 76 (70, 86)
B I, kg/m2 26 (23, 28) 26 (23, 28) 27 (23, 30)b 25 (23, 28) 24 (22, 27)b 24 (21, 27)c
U derweight, % 1.3 0.3 0.0b 3.3 2.9a 2.8a
N rmal-weight, % 43.7 39.0 31.0 42.6 60.0 56.0
O erweight, % 40.1 44.9 43.4 36.1 30.0 28.4
O ese, % 15.0 15.8 25.7 18.0 7.1 12.8
Waist circumference, cm 87 (79, 96) 88 (79, 97) 97 (82, 107)c 85 (78, 101) 89 (84, 100) 88 (79, 98)
H p circumference, cm 99 (94, 106) 100 (95, 106) 101 (95, 110)a 99 (94, 107) 97 (92, 102)a 97 (92, 102)b
Waist-to-hip ratio 0.87 (0.82, 0.93) 0.88 (0.81, 0.94) 0.92 (0.83, 1.00)c 0.88 (0.81, 0.97) 0.94 (0.88, 1.00)c 0.90 (0.85, 0.98)c
H A1c, mmol/mol 65 (57, 74) 64 (55, 73) 66 (59, 75) 67 (56, 77) 62 (53, 73) 64 (53, 75)
H A1c, % 8.1 (7.4, 8.9) 8.0 (7.2, 8.8) 8.2 (7.5, 9.0) 8.3 (7.3, 9.2) 7.8 (7.0, 8.8) 8.0 (7.0, 9.0)
T iglycerides, mmol/l 0.9 (0.7, 1.3) 1.0 (0.7, 1.2) 1.2 (0.9, 1.7)c 1.4 (0.9, 2.0)c 1.2 (1.0, 1.7)c 1.3 (0.9, 1.6)c
T tal cholesterol, mmol/l 4.5 (4.0, 5.1) 4.6 (4.0, 5.1) 4.4 (3.9, 4.9)a 4.0 (3.4, 4.7)c 3.8 (3.2, 4.4)c 4.2 (3.6, 4.8)c
H L cholesterol, mmol/l 1.6 (1.3, 1.9) 1.7 (1.4, 2.0)c 1.5 (1.2, 1.8) 1.4 (1.1, 1.7)b 1.3 (1.1, 1.6)c 1.4 (1.2, 1.7)b
L id-lowering medication, % 26.7 46.2c 56.5c 58.3c 72.5c 66.0c
A tihypertensive medication, % 35.9 66.0c 94.5c 100c 90.0c 94.3c
V scular hard event, % 6.1 19.6c 36.6c 38.7c 44.4c 41.8c
P oliferative retinopathy, % 22.0 42.6c 79.8c 88.5c 80.8c 94.5c
D ta are presented as frequencies or median (interquartile range). In these variables, comparisons between the highest eGFR group and the other groups were done with Chi-squared test and Mann-
W itney U test, respectively. eGFR, estimated glomerular filtration rate (unit ml/min/1.73 m2); SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body-mass index; underweight,
B I < 18.5 kg/m2; normal-weight, BMI 18.5–<25.0 kg/m2; overweight, BMI  25.0–<30 kg/m2; obese, BMI  30 kg/m2; vascular hard event, acute myocardial infarction, coronary bypass, stroke,
a putation, or peripheral vascular disease.
a < 0.05.
b < 0.01.
c < 0.001.
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Table 2 – Food consumption, compliance, and use of probiotics and dietary supplements divided by the renal status.
eGFR90n = 1118 eGFR60–89n = 396 eGFR30–59n = 115 eGFR<30n = 62 Dialysis n = 73 Transplant n = 110
Coffee, cups per day 3.5 (2.0, 5.0) 4.0 (2.0, 5.5) 3.5 (2.0, 4.5) 2.3 (1.0, 4.0)b 2.5 (1.5, 3.0)c 3.0 (2.0, 4.0)b
Tea, cups per day 0 (0, 1) 0 (0, 1) 0 (0, 1.5)b 0 (0, 2)a 0 (0, 1) 0 (0, 2)b
Liquid milk products, glasses per day 2.5 (1.0, 4.0) 2.0 (1.0, 3.0)c 2.0 (0.5, 3.0)b 1.0 (0, 2.0)c 1.0 (0, 2.0)c 2.0 (1.0, 3.0)a
Bread, slices per day 4.5 ± 2.3 4.5 ± 2.1 4.5 ± 1.9 4.3 ± 2.0 4.1 ± 2.8a 4.7 ± 2.3
Rye bread, % 85.4 83.5 80.9 35.5c 27.8c 81.5
Wheat bread, % 10.5 8.6 14.8 50.0c 65.3c 14.8
Vegetable oil-based spread, % 61.1 60.3 67.8 61.3 71.2 72.6a
Vegetable oil-based cooking fats, % 79.9 74.7a 77.4 71.0 68.5a 77.8
Aims at reducing salt consumption, % 20.8 31.1c 34.8b 39.3b 38.9b 30.8a
Probiotics, % 32.9 33.0 30.7 22.6 34.2 28.4
Dietary supplements, % 60.3 60.5 50.4a 43.5a 52.1 43.1b
Has received dietary counselling from
Dietitian, % 56.5 60.0 71.3b 83.9c 84.9c 76.6c
Nurse, % 52.6 54.9 56.5 41.9 38.4a 55.1
Physician, % 20.0 21.8 21.7 33.9a 30.1 25.2
Compliant, % 47.6 56.2b 61.1b 85.2c 75.3c 69.4c
Any special diet, % 28.7 33.2 59.1c 86.9c 77.8c 41.9b
Data are presented as median (interquartile range), mean ± standard deviation, or frequency. In these variables, comparisons between the highest eGFR group and the other groups were done with
Mann-Whitney U test, independent samples t-test, and Chi-squared test, respectively. eGFR, estimated glomerular filtration rate (unit ml/min/1.73 m2); Compliant, self-reportedly complies with the
dietary guidelines always or most of the time.
a p < 0.05.
b p < 0.01.
c p < 0.001.
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d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 7 5 5energy intake between 3349 and 14654 kJ (800 and 3500 kcal)
were included in the analyses of nutrient data.
2.4. Statistical analyses
Entries in the FFQ were submitted to an exploratory factor
analysis (maximal likelihood and varimax rotation) to yield
dietary patterns. Here, we included all factors with eigenval-
ues >1.0, and in each factor we included food items with fac-
tor loadings |0.20|. The factor score was the sum of the
scores for items associated with a particular factor multiplied
by its factor loading. Categorical observations are reported as
frequencies, and continuous variables are presented as
means ± standard deviations when normally distributed and
as medians (interquartile ranges) when non-normally dis-
tributed. In the analyses, all other groups were compared to
those with eGFR90. In addition individuals in dialysis and
those with kidney transplantation were compared. For cate-
gorical variables, the between-group comparisons were con-
ducted with Chi-squared test, and for continuous variables
with independent samples’ t-test and Mann-Whitney U test,
as appropriate. For analyses, IBM SPSS Statistics for Windows,
Version 22.0 (IBM Corp, Armonk, NY, USA) was used. A two-
tailed P value <0.05 denoted statistical significance.
3. Results
3.1. Study participants
Data were available from 1874 individuals (44.5% men, age
48.1 ± 13.4 years). Altogether, 59.7% had eGFR90 (index
group), 21.1% had eGFR60–89, 6.1% had eGFR30–59, 3.3% had
eGFR<30, 3.9% were on dialysis, and 5.9% were kidney trans-
plant recipients (Table 1). Individuals on dialysis and with a
kidney transplant were more frequently men compared to
those with normal or high eGFR. Compared to the index
group, age and diabetes duration were higher in all other
groups. Individuals on dialysis and those with a kidney trans-
plant had lower median BMI compared to those with intact
kidney function. Moreover, the distribution of participants
based on the four BMI classes differed significantly between
these groups; notably, the frequencies of underweight and
normal-weight individuals were higher, while those of over-
weight and obese were lower in the two advanced kidney dis-
ease groups. However, compared to the index group, the
median waist-to-hip ratios were higher in the two groups
with most advanced kidney disease.
3.2. Food consumption, supplement use, and diet
adherence
The median (interquartile range) of the time gap between the
dietary and renal assessment was 5 days (0, 30). Compared to
the index group, individuals with eGFR<30, those on dialysis,
and kidney transplant recipients reported consuming lower
numbers of coffee cups (Table 2). Liquid milk product con-
sumption was lower in all groups, compared to the index
group. Only among individuals on dialysis was the number
of bread slices consumed lower than in the index group. Dif-
Table 4 – Energy, macronutrient, sucrose, and fibre intake divided by the renal status.
eGFR90n = 839 eGFR60–89n = 332 eGFR30–59n = 83 eGFR<30n = 38 Dialysis n = 36 Transplant n = 71
Energy, MJ 8100 (6892, 9479) 7390 (6264, 8591)c 6794 (5991, 7931)c 6490 (5616, 7298)c 6872 (6070, 8376)c 6773 (6066, 7799)c
Energy, kJ/kg 110 ± 29 101 ± 27c 87 ± 27c 85 ± 22c 98 ± 26a 99 ± 25b
Carbohydrates, E% 42.7 ± 7.0 42.3 ± 6.9 44.3 ± 7.0 44.2 ± 6.8 42.7 ± 5.4 42.9 ± 7.4
Fats, E% 36.1 ± 6.2 36.0 ± 6.5 35.6 ± 7.2 37.7 ± 6.8 38.9 ± 4.6a 36.3 ± 5.8
SAFA, E% 12.8 ± 2.9 12.6 ± 3.0 12.0 ± 3.1a 12.3 ± 3.3 13.9 ± 2.9a 12.7 ± 2.5
MUFA, E% 12.0 (10.6, 13.8) 11.9 (10.4, 13.5) 12.2 (10.4, 14.0) 13.2 (10.6, 15.2) 13.3 (12.0, 14.5)b 11.8 (10.3, 13.5)
PUFA, E% 5.9 (5.0, 6.9) 5.8 (4.9, 7.1) 6.3 (5.2, 7.5) 6.6 (5.4, 8.1)b 6.2 (5.5, 7.2) 6.1 (5.2, 7.2)
Proteins, E% 16.6 (14.8, 18.5) 17.1 (15.3, 19.0)a 15.9 (14.6, 18.0) 15.4 (13.7, 17.3)a 16.0 (14.5, 18.0) 16.7 (15.0, 19.3)
Proteins per kg 1.07 (0.88, 1.29) 1.02 (0.85, 1.20)b 0.85 (0.69, 1.00)c 0.77 (0.65, 0.96)c 0.96 (0.80, 1.13)a 0.97 (0.83, 1.16)a
Alcohol, E% 0.9 (0, 3.1) 1.0 (0, 3.1) 0 (0, 1.9)a 0 (0, 0.9)b 0 (0, 1.0)b 0.4 (0, 1.9)
Sucrose, E% 7.1 (5.0, 9.8) 6.5 (4.6, 9.1)a 6.0 (4.8, 9.1) 5.9 (4.7, 7.8)a 7.2 (6.0, 10.3) 6.6 (3.5, 8.7)a
Fibre, g/MJ 2.7 (2.2, 3.3) 3.0 (2.4, 3.6)c 2.9 (2.4, 3.8)c 2.7 (2.2, 3.2) 2.2 (1.9, 2.6)a 2.9 (2.5, 3.6)b
Na, g 2.8 (2.4, 3.3) 2.7 (2.2, 3.1)c 2.6 (2.0, 3.1)c 2.5 (2.2, 2.9)b 2.7 (2.2, 3.3) 2.7 (2.2, 3.2)a
K, g 4.0 (3.3, 4.7) 3.9 (3.4, 4.6) 3.8 (3.1, 4.6)b 3.0 (2.4, 3.7)a 2.9 (2.6, 3.3)c 3.4 (3.1, 4.1)c
Ca, g 1.1 (0.8, 1.4) 1.0 (0.8, 1.3)c 0.8 (0.6, 1.1)c 0.5 (0.4, 0.7)a 0.7 (0.5, 1.0)c 0.9 (0.8, 1.1)c
P, g 1.6 (1.3, 1.9) 1.5 (1.3, 1.8)b 1.3 (1.0, 1.7)c 1.1 (0.9, 1.2)a 1.2 (1.0, 1.4)c 1.4 (1.2, 1.7)c
Data are presented as median (interquartile range) or mean ± standard deviation. In these variables, comparisons between the highest eGFR group and the other groups were done with Mann-
Whitney U test, and independent samples t-test, respectively. eGFR, estimated glomerular filtration rate (unit ml/min/1.73 m2); E%, percentage of energy intake; SAFA, saturated fatty acids; MUFA,
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; Na, sodium; K, potassium; Ca, calcium; P, phosphorus.
a p < 0.05.
b p < 0.01.
c p < 0.001.
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ever. A significantly lower frequency of rye bread consump-
tion was observed in those with eGFR<30 and dialysis, but
reached the level of those in the index group in kidney trans-
plant recipients. In contrast, the frequencies of wheat bread
consumption were higher in eGFR<30 and dialysis. Compared
to the index group, there was a higher frequency of partici-
pants aiming at reducing salt consumption in all other
groups. The use of probiotic supplements did not differ
between the groups. Instead, the use of vitamin or mineral
supplements was less frequent in those with eGFR30–59,
eGFR<30, and in kidney transplant recipients. The frequencies
of individuals reporting having received dietary advice from a
dietitian was higher in all groups except in eGFR60–89, as
compared to those with normal or high eGFR. Compared to
the index group, the rate of self-reported compliance with
dietary recommendations was higher in all groups. Special
diet adherence was more frequent in all groups from
eGFR30–59 onwards.
The differences in food consumption between individuals
on dialysis and kidney transplant recipients was also investi-
gated. Liquid milk product consumption (p < 0.001) and the
number of bread slices eaten (p = 0.019) were higher in kidney
transplant recipients. Moreover, the frequency of reporting
rye bread consumption (p < 0.001) was higher, while that of
wheat bread (p < 0.001) was lower in kidney transplant recip-
ients. Finally, the frequency of special diet adherence
(p < 0.001) was lower in those with kidney transplantation.
3.3. Dietary patterns
Seven dietary patterns were generated in the factor analysis
(Supplementary Table 1). Compared to the index group, signif-
icantly lower High-fat cheese pattern scores were observed in
those on dialysis (Table 3). Fish and vegetable pattern scores
were higher in eGFR30–59 than in those with normal or high
eGFR. In all groups were the Sweet pattern scores lower com-
pared with the index group. However this difference did not
reach statistical significance in the dialysis group. Those with
eGFR60–89 had higher, and those on dialysis had lower
Healthy snack pattern scores. In eGFR<30, Meat and potatos
pattern scores were higher compared to the index group.
Instead, the pattern scores of Pasta, rice and poultry were
lower in eGFR60–89, eGFR30–59, and kidney transplant
recipients.
Of the diet patterns, compared to the individuals on dialy-
sis, kidney transplant recipients had higher scores in Fish and
vegetables (p = 0.031), and Healthy snack (p < 0.001). Instead,
the scores of Pasta, rice and poultry (p = 0.002) were lower in
the kidney transplant recipients.
3.4. Energy and nutrient intake
In all, 1399 participants (41.7% men, age 48.9 ± 13.7 years)
completed food records with plausible reported energy intake.
All groups reported lower total energy intake compared to the
index group (Table 4). Carbohydrate intake was comparable
between the groups, but those on dialysis reported higher
energy intake from fats. Compared to the index group, higherand lower energy intake from proteins was observed in
eGFR60–89 and eGFR<30, respectively. Instead, protein intake
in g/kg were, in all groups, lower than that in the index group.
Lower sucrose intake was observed in eGFR60–89, eGFR<30,
and kidney transplant recipients. Compared to the index
group, those with eGFR60–89, eGFR30–59, and kidney trans-
plant had higher, while those on dialysis lower fibre intake.
The intakes of sodium, potassium, calcium, and phosphorus
tended to be lower in all groups compared to the index group.
Compared to the individuals on dialysis, the percentage of
energy from total fats (p = 0.036), saturated fatty acids
(p = 0.038), and monounsaturated fatty acids (p = 0.017) were
lower in kidney transplant recipients. In contrast, the intakes
of fibre (p < 0.001), potassium (p < 0.001), calcium (p < 0.001),
and phosphorus (p < 0.001) were higher in kidney trans-
planted individuals.
4. Discussion
To the best of our knowledge, this is the first study to investi-
gate dietary intake at the levels of foods, dietary patterns, and
nutrients in T1D at different stages of renal disease. We
observed significant differences at all levels of dietary intake
between those with normal renal function and those with dif-
ferent levels of renal deterioration. Based on higher self-
reported compliance, greater aims at reducing salt intake,
and lower scores in the diet pattern related to the intake of
sweet food items, it seems that there was a general trend
towards healthier food choices upon advancing kidney dis-
ease, despite obvious dietary restrictions. Indeed, many of
the observed differences, such as reduction in the consump-
tion of milk products and rye bread, higher frequencies of
wheat bread consumption and special diet adherence, and
reduced protein intake are likely signs of individuals follow-
ing a diet plan aimed at delaying or managing kidney failure.
A number of differences were also observed between individ-
uals on dialysis and kidney transplant recipients. Amongst
others, differences in milk product and bread consumption
were seen. Importantly, a 36 percentage-point reduction in
adherence to special diets likely represents the liberation
from dietary restrictions imposed upon dialysis. Dietary liber-
ation was also observed at micronutrient level, as kidney
transplant recipients reported higher fibre, potassium, cal-
cium, and phosphorus intakes.
Of importance, dietary intake did not only differ between
individuals with intact kidney function and in more advanced
kidney failure, but many of the differences were obvious
already at the earlier stages of renal deterioration. The rea-
sons or consequences of these differences are not known
and, as most of the previous studies have quite exclusively
focused on the dietary intake when renal deterioration has
already progressed into end-stage renal disease, comparing
these observations with the previous ones is challenging. In
one study assessing dietary intake in haemodialysis, lower
intakes of total energy, protein, and calcium were reported
in individuals with diabetes compared to those without [18].
Another study of haemodialysis reported higher intakes of
total energy, protein, fat, and fibre in men with diabetes com-
pared to men without [19]. Moreover, compared to women
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drate but higher fibre intakes. In both sexes, individuals with
diabetes reported lower sodium but higher potassium and
phosphorus intakes compared to their non-diabetic counter-
parts. We found one study in T1D reporting dietary intake
before and after islet transplantation [20]. In that study, no
differences were observed in the intakes of energy or fibre,
or proportions of energy derived from carbohydrates, fats
and proteins before and after transplantation. Instead, signif-
icant reduction in phosphorus intake following the transplan-
tation was reported.
While the number of studies on dietary intake at various
stages of renal disease is limited, a larger number of papers
have been published on the association between diet and kid-
ney failure progression. Of the macronutrients, protein has
probably gained the most interest and a number of meta-
analyses have been published on the subject. The authors of
a Cochrane meta-analysis including 7 randomized controlled
trials concluded that protein restriction in T1D resulted in
non-significant reduction in the GFR decline [21]. In contrast,
the authors of a more recent meta-analysis concluded that
protein restriction slowed CKD progression in individuals
without diabetes and in T1D, but not in type 2 [22]. Yet in
another meta-analysis of 13 randomized controlled trials
including 779 participants with either type 1 or type 2 dia-
betes, low-protein diet was associated with significant
improvement in GFR, an effect that was consistent across
the diabetes subgroups [23]. However, this improvement was
evident only when compliance to the diet was fair. Impor-
tantly, not only poor adherence to the prescribed diet, but also
short duration of the trials, may mask the true effects of pro-
tein restriction. Partly due to the mixed results, it has also
been suggested that the potential kidney sparing effect may
not be directly related to the reduced protein intake, but
may be confounded by the concomitant reduction in the salt
or saturated fatty acid intakes [24]. While it remains unclear
whether protein restriction slows the progression of diabetic
kidney disease, there may be value in reduced-protein diets
in patients with overt kidney failure. In these patients, how-
ever, the potential for malnutrition and hypoalbuminaemia,
related to low-protein diet, need to be acknowledged [24]. Of
note, the proportion of underweight participants amongst
those on dialysis and with kidney transplant was also
observed in the current study. At the same time, we observed
higher waist-to-hip ratios in these two groups, suggesting
that instead of losing fat mass these individuals had rather
lost lean tissue.
The role of other dietary macronutrients in the diabetic
kidney disease has been less investigated. One case report
of a type 2 diabetes patient reducing his daily carbohydrate
intake to 80–90 g, equalling to 20% of energy from carbohy-
drates, showed both improved glycaemic control and reversal
of a 6-year long decline in renal function [25]. The authors of a
paper describing a 12-month intervention with moderate low-
carbohydrate diet (38 E% carbohydrates), reported remarkable
reduction in the urinary albumin excretion in individuals
with type 2 diabetes and baseline microalbuminuria [26].
Studies in T1D are, again, scarce but in one such study 11
adult individuals adhering to a low-carbohydrate high-fatketogenic diet (6 E% carbohydrates, 65 E% fats) displayed no
or little evidence of renal dysfunction [27].
Importantly, foods and nutrients are not consumed in iso-
lation, but cluster to form dietary patterns. These dietary pat-
terns offer an attractive avenue for studying the association
between diet and health. AWestern dietary pattern, for exam-
ple, characterized by high intakes of red meat, refined grains,
and high-sugar drinks and desserts, has typically been associ-
ated with inflammation, impairment of renal vascular func-
tion, and decrease in kidney function [28,29]. A prudent diet,
instead, defined as closer adherence with dietary recommen-
dations, has proven beneficial for the kidneys as individuals
with type 2 diabetes in the highest tertile of healthy eating
index, compared to those in the lowest, showed reduced inci-
dence or progression of CKD [6]. The Dietary Approaches to
Stop Hypertension (DASH) diet pattern is another example
of a prudent dietary pattern, and is characterized by high
intakes of fruits, vegetables, nuts, legumes, low-fat dairy
products, and whole grains, but low intakes of sodium, sweet-
ened beverages, and red and processed meats. In the Nurses’
Health Study, individuals in the top quartile of the DASH-diet
score, compared to those in the bottom quartile, had signifi-
cantly decreased risk of rapid eGFR decline [29]. Finally, of
the factor analysis-derived dietary patterns, one with abun-
dant intake of fish and vegetables was associated with better
kidney function in a cross-sectional study of individuals with
type 2 diabetes [30].
The use of validated methods to study dietary intake and a
well-defined study population are notable strengths of this
study. There are, however, also important limitations that
need to be addressed. Despite a fair number of participants
in this study, the numbers of individuals in some of the
groups of renal status were quite modest. Also, individuals
taking part in health-related studies may be different from
the ones that decline to participate. It is likely, for example,
that individuals with greater interest in health and diet, in
particular, are over-represented in the current sample. Taken
together, these could reduce the generalizability of the results
to the T1D population at large. As this is a cross-sectional
study, inferences about the role of diet in the progression of
renal disease cannot be made. Instead, our aim was rather
to evaluate the current diet of individuals in different stages
of renal disease. This study will serve as a baseline for future
analyses where the longitudinal associations will be assessed.
The use of self-reported methods for measuring dietary
intake is a common practice in epidemiological studies. How-
ever, these methods are prone to misreporting, and it has
been suggested that self-report methods should not, for
example, be used to assess absolute energy intake [31]. Due
to social desirability, there may also be a tendency for partic-
ipants to over- and under-report food items that are consid-
ered healthy and unhealthy, respectively. In the current
study we used two separate methods, with partly different
sources of error, to study dietary intake. The potential for mis-
reporting remains, however, and it is not known whether
renal status is associated with the level of misreporting.
In conclusion, results from the current study suggest that
dietary intake differ based on the level of renal status. Differ-
ences were observed, not only at advanced kidney disease,
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 5 ( 2 0 1 9 ) 1 0 7 7 7 5 9but already at earlier stages of eGFR decline. The observed dif-
ferences reflected the recommendations typically imposed to
individuals with T1D with deteriorating renal function. While
receiving a kidney transplant marks the end of a more restric-
tive diet of pre-dialysis and dialysis periods, the diets of the
kidney transplant recipients, with many respect, still differed
from those with intact renal function.
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